Medco Holdings Past Earnings Performance

Past criteria checks 0/6

Medco Holdings's earnings have been declining at an average annual rate of -23.3%, while the Capital Markets industry saw earnings growing at 5.7% annually. Revenues have been declining at an average rate of 71.7% per year.

Key information

-23.3%

Earnings growth rate

-26.2%

EPS growth rate

Capital Markets Industry Growth21.0%
Revenue growth rate-71.7%
Return on equity-12.7%
Net Margin-308.3%
Last Earnings Update30 Sep 2024

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown

How Medco Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

PSE:MED Revenue, expenses and earnings (PHP Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 241-440
30 Jun 242-440
31 Mar 240-540
31 Dec 230-640
30 Sep 230-640
30 Jun 230-640
31 Mar 230-640
31 Dec 220-540
30 Sep 220-550
30 Jun 220-650
31 Mar 220-650
31 Dec 21-1-640
30 Sep 210-640
30 Jun 210-740
31 Mar 210-540
31 Dec 200-540
30 Sep 203-340
30 Jun 203-240
31 Mar 206140
31 Dec 196140
30 Sep 199440
30 Jun 199440
31 Mar 199340
31 Dec 189340
30 Sep 1856070
30 Jun 1855970
31 Mar 1866170
31 Dec 1766070
30 Sep 17100100
30 Jun 1790100
31 Mar 179-2100
31 Dec 169-1100
30 Sep 166-490
30 Jun 166-4100
31 Mar 166-4100
31 Dec 156-4100
30 Sep 153-7120
30 Jun 153-7110
31 Mar 151-9110
31 Dec 143-8110
30 Sep 144-10120
30 Jun 144-10120
31 Mar 143-12120
31 Dec 131-14120

Quality Earnings: MED is currently unprofitable.

Growing Profit Margin: MED is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: MED is unprofitable, and losses have increased over the past 5 years at a rate of 23.3% per year.

Accelerating Growth: Unable to compare MED's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: MED is unprofitable, making it difficult to compare its past year earnings growth to the Capital Markets industry (21.9%).


Return on Equity

High ROE: MED has a negative Return on Equity (-12.66%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 05:22
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Medco Holdings, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution